Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Study on the Correlation Between the Level of Neurofilament Light Chain Protein and the Sensitivity to Remazolam in Older Adults

NCT07280663 is registered in ClinicalTrials.gov with Second Hospital of Shanxi Medical University as lead sponsor.

NCT NCT07280663
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07280663 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Study on the Correlation Between the Level of Neurofilament Light Chain Protein and the Sensitivity to Remazolam in Older Adults
Lead sponsor
Second Hospital of Shanxi Medical University
Phase
Phase 1
Overall status
Completed
Start date
October 9, 2025
Completion date
October 9, 2025
Enrollment
128 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

old age